Connect with Alexa
D'Angelo's research focuses on insurance-related barriers to equitable access to quality care and financial protection from illness, as well as a specific focus on the spectrum of systemic barriers to universal PrEP access in the U.S. Overarching themes in D'Angelo's writings include a focus on the for-profit, systemic healthcare drivers of health inequity, LGBTQ health and HIV prevention.
Explores how public health academics perceive their role in influencing health policy and advocating for single-payer. Explains public health academics hold varied perspectives regarding their role in influencing policy, including single-payer polices, with some more certain of their role than others.
Asks the question-- how do public health academics perceive their role in influencing health policy? Focuses on how public health academics see their role in advocating for a single-payer system in the U.S. Reveals constraints regarding their advocacy role, as well as offered strategies for academics advocating for single-payer. Contributes to the extant literature on scholar-activism and offer recommendations for encouraging advocacy within the Academy.
Ellaborates on barriers that arose for PrEP-using gay and bisexual men, as well as facilitating factors that aided PrEP persistence, with the goal of informing PrEP implementation efforts. Shows emergent themes regarding the barriers and facilitators to PrEP persistence fell into two categories: insurance- and medical appointment-related barriers and facilitators to PrEP use. Hopes that our findings can provide useful insights for providers, program developers, and policymakers.
Reports on the experiences of transmasculine individuals during the early pandemic, specifically focusing on how participants navigated access to gender-affirming care and other healthcare during a time of reduced access to in-person care.
Shows some of the strategies that have been used to challenge patents on HIV treatment and prevention drugs both in the U.S. and globally. Reviews several case studies of efforts to overturn patents, with the hope that we can glean lessons from these cases to inform efforts to improve access to generic COVID-19 treatment and prevention medicines and technologies.